Characterization of APOE Christchurch carriers in 455,306 UK Biobank participants-Reference-Cited by-同舟云学术

Characterization of APOE Christchurch carriers in 455,306 UK Biobank participants

Published:2023-11-28 Issue:1 Volume:18 Page:
ISSN:1750-1326
Container-title:Molecular Neurodegeneration
language:en
Short-container-title:Mol Neurodegeneration

Author:

He Karen Y.^ORCID,Khramtsova Ekaterina A.,Cabrera-Socorro Alfredo,Zhang Yanfei,Li Shuwei,Sarver Brice A. J.,Smets Bart,Li Qingqin S.,De Muynck Louis,Parrado Antonio R.,Lovestone Simon,Black Mary Helen

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Neurology (clinical),Molecular Biology

Link

https://link.springer.com/content/pdf/10.1186/s13024-023-00684-7.pdf

Reference16 articles.

1. Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 1988;240(4852):622–30.

2. Yamazaki Y, Zhao N, Caulfield TR, Liu CC, Bu G. Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies. Nat Rev Neurol. 2019;15(9):501–18.

3. Bu G. APOE targeting strategy in Alzheimer’s disease: lessons learned from protective variants. Mol Neurodegener. 2022;17(1):51.

4. Rabinovici GD, Dubal DB. Rare APOE Missense Variants-Can We Overcome APOE epsilon4 and Alzheimer Disease Risk? JAMA Neurol. 2022;79(7):649–51.

5. Arboleda-Velasquez JF, Lopera F, O’Hare M, Delgado-Tirado S, Marino C, Chmielewska N, et al. Resistance to autosomal dominant Alzheimer’s disease in an APOE3 Christchurch homozygote: a case report. Nat Med. 2019;25(11):1680–3.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multifaceted roles of APOE in Alzheimer disease;Nature Reviews Neurology;2024-06-21